Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 15;22(1):372.
doi: 10.1186/s12872-022-02810-7.

Association of hyperuricemia with apolipoprotein AI and atherogenic index of plasma in healthy Chinese people: a cross-sectional study

Affiliations

Association of hyperuricemia with apolipoprotein AI and atherogenic index of plasma in healthy Chinese people: a cross-sectional study

Yan Duan et al. BMC Cardiovasc Disord. .

Abstract

Background: The atherogenic index of plasma (AIP) is a predictor for cardiovascular diseases (CVD), while hyperuricemia is an independent risk factor for a variety of CVD. Apolipoprotein AI has been found to be a protective factor for CVD. However, the role of APO AI in the association between plasma uric acid and AIP among healthy Chinese people needs to be further explored.

Aims: To evaluate the relationship between blood uric acid and AIP level in healthy Chinese people. To evaluate the relationship between blood uric acid and Apolipoprotein AI in healthy Chinese people.

Method: A total of 3501 normal and healthy subjects who had physical examinations were divided into the hyperuricemia (HUA) group and the normouricemia (NUA) group.

Result: The AIP of HUA group was significantly higher than that of NUA group [0.17±0.30 vs. -0.08±0.29]. Apo AI (1.33 ± 0.21 vs. 1.47 ± 0.26 g/l) and HDL-c (1.12 ± 0.27 vs. 1.36 ± 0.33 mmol/l) were significantly lower in the HUA group than in the NUA group. LDL-C (2.81 ± 0.77 vs. 2.69 ± 0.73 mmol/l), Apo B (0.96 ± 0.20 vs. 0.89 ± 0.20 g/l), FBG (5.48 ± 0.48 vs. 5.36 ± 0.48 mmol/l) and HOMA-IR [2.75 (1.92-3.91) vs. 2.18 (1.50-3.12)] was significantly higher in HAU group than the NUA group. Increases in plasma UA were associated with increases in AIP (β = 0.307, p < 0.01) and decreases in Apo AI (β = - 0.236, p < 0.01).

Conclusion: Hyperuricemia is an independent risk factor for high AIP level. Inhibition of Apolipoprotein AI may be one of the mechanisms of UA which is involved in the progression of cardiovascular disease.

Keywords: AIP; Apo AI; Hyperuricemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Comparison of lipid metabolism indices between HUA and NUA group. Bar graph of Lipid metabolism indices (A HDL-c; B Apo AI; C LDL-c; D Apo-B) mean value with SD intervals between NUA and HUA groups. *p < 0.05, **p < 0.01. UA uric acid, HDL-c high-density lipoprotein cholesterol, Apo AI apolipoprotein A1, LDL-c low-density lipoprotein cholesterol, Apo B apolipoprotein B
Fig. 2
Fig. 2
Comparison of glucose metabolism indices between HUA and NUA group. Bar graph of glucose metabolism indices (A FBG; B INS; C HOMA-IR; D HOMA-β) mean value with SD intervals or median with quartiles between NUA and HUA groups. *p < 0.05, **p < 0.01. FBG Fasting blood glucose, INS insulin, HOMA-IR homeostasis model assessment of insulin resistance, HOMA-β homeostasis model assessment of β-cell function
Fig. 3
Fig. 3
The correlation between plasma UA and AIP. Correlation analysis was used to prove the linear relationship between plasma UA and AIP. Plasma UA was positively correlated with AIP
Fig. 4
Fig. 4
Correlation between plasma UA and the levels of Apo AI and HDL-c. Correlation analysis was used to prove the linear relationship between plasma UA and the levels of Apo AI (A) and HDL-c (B). Plasma UA was negatively correlated with Apo AI and HDL-C

Similar articles

Cited by

References

    1. Anesthesiology NJSO. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971–1992. Surv Anesthesiol. 2001;45(2):121–122. doi: 10.1097/00132586-200104000-00057. - DOI
    1. Holme I, et al. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) J Intern Med. 2009;266(6):558–570. doi: 10.1111/j.1365-2796.2009.02133.x. - DOI - PubMed
    1. Culleton BF, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131:7–13. doi: 10.7326/0003-4819-131-1-199907060-00003. - DOI - PubMed
    1. Strasak AM, et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol. 2008;125(2):232–239. doi: 10.1016/j.ijcard.2007.11.094. - DOI - PubMed
    1. Casiglia E, et al. Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values. J Hypertens. 2019;38(3):1. - PMC - PubMed

Publication types

LinkOut - more resources